Workstream Type: Data Analysis

  • Pricing in the Market for Anticancer Drugs

  • The 340B Program: Hospitals Profit by Reaching Affluent Communities

  • Limits on Medicare’s Ability to Control Rising Spending on Cancer Drugs

  • Targeted Drugs for Metastatic Renal Cell Carcinoma